期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

用于冠状动脉闭塞介入治疗的微导管研究

Study of microcatheter for chronic total occlusion
下载PDF
导出
摘要 微导管是冠状动脉慢性全闭塞病变经皮冠状动脉介入治疗中的关键器械之一。基于微导管中间层的特点,将其分为绕丝结构、编织结构、复合结构。本研究综述了3种结构微导管的产品特性及其对应的临床特点,对新研发的Blue Arrow微导管的特性进行了对比研究。 Microcatheter plays an important role in chronic total occlusion(CTO)percutaneous coronary intervention.Based on the construction,microcatheter can be classified as coil-based,braiding-based and composite-based.From the point of view of construction and the performance,commercialized microcatheters were reviewed in this paper.A latest designed microcatheter named Blue Arrow was introduced as well.
作者 向东东 王平 于伟 肖建平 张钲 Xiang Dong-dong;Wang Ping;Yu wei;Xiao Jian-ping;Zhang Zheng(Shenzhen Yeapro Industrial Company Limited,Shenzhen518000,Guangdong,China;Department of Cardiovascular,The First Hospital of Lanzhou University,Lanzhou730000,China)
机构地区 深圳市业聚实业有限公司 兰州大学第一医院心内科
出处 《兰州大学学报（医学版）》 CAS 2019年第4期84-88,共5页 Journal of Lanzhou University（Medical Sciences）
基金 中央高校基本科研业务费专项资金项目(lzujbky-2019-kb17)
关键词 微导管 冠状动脉慢性全闭塞 绕丝结构 编织结构 复合结构 microcatheter chronic total occlusions coil-based braiding-based composite-based
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献7

二级参考文献67

  • 1Schwartz RS. Cardiac CTA, three-dimensions, and the chronic total occlusion: A window to the future [J]. Catheter CardiovascInterv, 2008, 71 (6):790-791.
  • 2Hsu JT, Tamai H, Kyo E, et al. Traditional antegrade approach versus combined antegrade and retrograde approach in the percutaneous treatment of coronary chronic total occlusions [J]. Catheter Cardiovasc Interv, 2009, 74 (4): 555-563.
  • 3Chung SH, Kim MH, Yu LH, et al. Initial experience of retrograde wire approach in coronary chronic total occlusion intervention [J]. Korean Circ J, 2009, 39 (6): 228-235.
  • 4Sirnes PA, Golf S, Myreng Y, et al. Stenting in chronic coronary occlusion (SICCO): randomized, controlled trial of adding stent implantation after successful angioplasty [J]. J Am Coll Cardiol, 1996, 28 (6): 1444-1451.
  • 5Suzuki S, Furui S, Isshiki T, et ah Methods to reduce patients' maximum skin dose during percutaneous coronary intervention for chronic total occlusion [ J ]. Catheter Cardiovase Interv, 2008, 71 (6): 792-798.
  • 6Suzuki S, Furui S, Isshiki T, et al. Patients' skin dose during percutaneous coronary intervention for chronic total occlusion [J]. Catheter Cardiovasc Interv, 2008, 71 (2): 160-164.
  • 7Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20 year experience [J]. J Am Coll Cardiol, 2001, 38 (2): 409-414.
  • 8Lotan C, Rozenman Y, Hendler A, et al. Stents in total occlusion for restenosis prevention: the multicenter randomized STOP study [J]. Eur Heart J, 2000, 21 (23): 1960-1966.
  • 9Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology [J]. Eur Heart J, 2005, 26 (8): 804-847.
  • 10Hoye A, van Domburg RT, Sonnenschein K, et al. Percutaneous coronary intervention for chronic total occlusions: the thoraxcenter experience 1992-2002 [J]. Eur Heart J, 2005, 26 (24): 2630-2636.

共引文献16

兰州大学学报（医学版）
2019年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部